{"schema_version":"alpha-profile-public-v1","slug":"craig-b-thompson-m-d","canonical_url":"https://registry.alpha.ac/people/craig-b-thompson-m-d","as_of":"2026-09-13T05:23:05.753257+00:00","published_at":"2026-09-02T04:20:44.357425+00:00","last_reviewed_at":"2026-05-15T19:32:08.832+00:00","identity":{"display_name":"Craig B. Thompson, M.D.","headshot_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/ae740981-b7bf-4e7f-92fb-0dc504ef96c4.jpg","headshot_media":{"asset_id":"alpha-profile-portrait:craig-b-thompson-m-d:v1","canonical_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/ae740981-b7bf-4e7f-92fb-0dc504ef96c4.jpg","alt_text":"Portrait of Craig B. Thompson, M.D.","caption":"Craig B. Thompson, M.D. profile portrait","source_name":"Alpha governed canonical profile record","source_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/ae740981-b7bf-4e7f-92fb-0dc504ef96c4.jpg","rights":null,"authenticity_class":null,"published_at":"2026-09-02T04:20:44.357425+00:00","current_version":1},"profile_kind":"director","role_tags":["director","executive","board"],"current_role":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=craig-b-thompson-m-d","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=craig-b-thompson-m-d&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"roles":[],"claims":[{"claim_type":"ai_expertise","claim_value":{"detail":"Dr. Turner has served as Chief Medical Officer since March 2021, previously serving as Vice President of Clinical Development at Blueprint Medicines where he oversaw the approval of GAVRETO. He is board certified in Pediatrics and Pediatric Hematology and Oncology and previously held roles at ARIAD Pharmaceuticals and Celldex Therapeutics.","ai_expertise":false},"claim_text":"SEC-derived executive row classified AI expertise as False.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:36.795186+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NUVL executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:46.329356+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_expertise","claim_value":{"detail":"Medical expert with over 20 years at Biogen Inc. specializing in clinical development and safety sciences.","ai_expertise":false},"claim_text":"SEC-derived executive row classified AI expertise as False.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:15.433956+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VRTX executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:45.028877+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_governance_relevance","claim_value":{"reasons":[],"relevant":false},"claim_text":"AI-governance relevance classified as False from role/title and SEC-derived executive context.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:15.433956+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VRTX executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:45.028877+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_governance_relevance","claim_value":{"reasons":[],"relevant":false},"claim_text":"AI-governance relevance classified as False from role/title and SEC-derived executive context.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:36.795186+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NUVL executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:46.329356+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Craig B. Thompson, M.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T19:32:08.989523+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"REGN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817925000518/regn013211-def14a.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-15T19:32:08.887014+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Executive extraction classified AI/ML experience for Carl Dambkowski, M.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-14T23:32:07.634511+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"APGE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526177342/apge-20260424.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-14T23:32:07.478893+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_membership","claim_value":{"ticker":"REGN","role_type":"Director","organization":"Regeneron Pharmaceuticals, Inc."},"claim_text":"Serves on the board of Regeneron Pharmaceuticals, Inc. as Director.","claim_state":"verified","valid_from":"2022-01-01","valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:40.576371+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Regeneron Pharmaceuticals, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:44.446969+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Craig B. Thompson, M.D. currently serves as Director at Regeneron Pharmaceuticals, Inc..","claim_state":"verified","valid_from":"2025-04-29","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T19:32:08.95244+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"REGN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817925000518/regn013211-def14a.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-15T19:32:08.887014+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Technology"],"claim_text":"Craig B. Thompson, M.D. serves on Technology.","claim_state":"verified","valid_from":"2025-04-29","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T19:32:08.96968+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"REGN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817925000518/regn013211-def14a.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-15T19:32:08.887014+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":{"committees":["Technology"]},"claim_text":"Committee assignments at Regeneron Pharmaceuticals, Inc.: Technology.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:40.576371+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Regeneron Pharmaceuticals, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:44.446969+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Executive extraction classified cybersecurity experience for Carl Dambkowski, M.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-14T23:32:07.669909+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"APGE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526177342/apge-20260424.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-14T23:32:07.478893+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Craig B. Thompson, M.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T19:32:09.026319+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"REGN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817925000518/regn013211-def14a.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-15T19:32:08.887014+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"director_since","claim_value":{"start_date":null,"director_since":2022},"claim_text":"Director tenure at Regeneron Pharmaceuticals, Inc. begins from 2022.","claim_state":"verified","valid_from":"2022-01-01","valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:40.576371+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Regeneron Pharmaceuticals, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:44.446969+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"MapLight Therapeutics, Inc.","claim_text":"Christopher A. Kroeger, M.D. is associated with MapLight Therapeutics, Inc..","claim_state":"verified","valid_from":"2026-04-29","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-04T23:51:09.232377+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MPLT DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1770069/000119312526191449/d121249ddef14a.htm","published_at":"2026-04-29T00:00:00+00:00","last_checked_at":"2026-05-04T23:51:09.051712+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"Heartflow, Inc.","claim_text":"Campbell D.K. Rogers, M.D. is associated with Heartflow, Inc..","claim_state":"verified","valid_from":"2026-04-29","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-04T23:11:07.825751+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"HTFL DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1464521/000119312526189307/d54880ddef14a.htm","published_at":"2026-04-29T00:00:00+00:00","last_checked_at":"2026-05-04T23:11:07.653444+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"Apogee Therapeutics","claim_text":"Carl Dambkowski, M.D. is associated with Apogee Therapeutics.","claim_state":"verified","valid_from":"2026-04-24","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-14T23:32:07.617975+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"APGE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526177342/apge-20260424.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-14T23:32:07.478893+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"Larimar Therapeutics, Inc.","claim_text":"Carole S. Ben-Maimon, M.D. is associated with Larimar Therapeutics, Inc..","claim_state":"verified","valid_from":"2026-04-20","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-04T23:43:38.208075+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"LRMR DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1374690/000119312526163942/lrmr-20260416.htm","published_at":"2026-04-20T00:00:00+00:00","last_checked_at":"2026-05-04T23:43:38.00844+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"Nuvalent Inc","claim_text":"Christopher D. Turner, M.D. is associated with Nuvalent Inc.","claim_state":"verified","valid_from":"2026-02-26","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T19:40:56.778567+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NUVL 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1861560/000119312526073317/nuvl-20251231.htm","published_at":"2026-02-26T00:00:00+00:00","last_checked_at":"2026-05-01T19:40:56.595118+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"Vertex Pharmaceuticals Incorporated","claim_text":"Carmen Bozic, M.D. is associated with Vertex Pharmaceuticals Incorporated.","claim_state":"verified","valid_from":"2026-02-13","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-04-25T00:26:49.700694+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VRTX 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000056/vrtx-20251231.htm","published_at":"2026-02-13T00:00:00+00:00","last_checked_at":"2026-04-25T00:26:49.576305+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":{"ticker":"NUVL","company":"Nuvalent Inc"},"claim_text":"Christopher D. Turner, M.D. is associated with Nuvalent Inc.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:36.795186+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NUVL executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:46.329356+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":{"ticker":"VRTX","company":"Vertex Pharmaceuticals Incorporated"},"claim_text":"Carmen Bozic, M.D. is associated with Vertex Pharmaceuticals Incorporated.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:15.433956+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VRTX executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:45.028877+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_function","claim_value":{"role_family":"other_executive","role_type_normalized":"other_executive"},"claim_text":"Christopher D. Turner, M.D. maps to the other executive executive function.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:36.795186+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NUVL executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:46.329356+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_function","claim_value":{"role_family":"other_executive","role_type_normalized":"evp"},"claim_text":"Carmen Bozic, M.D. maps to the other executive executive function.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:15.433956+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VRTX executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:45.028877+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"President, Chief Executive Officer and Director","claim_text":"Christopher A. Kroeger, M.D. is listed as President, Chief Executive Officer and Director at MapLight Therapeutics, Inc..","claim_state":"verified","valid_from":"2026-04-29","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-04T23:51:09.209577+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MPLT DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1770069/000119312526191449/d121249ddef14a.htm","published_at":"2026-04-29T00:00:00+00:00","last_checked_at":"2026-05-04T23:51:09.051712+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"Chief Medical Officer","claim_text":"Campbell D.K. Rogers, M.D. is listed as Chief Medical Officer at Heartflow, Inc..","claim_state":"verified","valid_from":"2026-04-29","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-04T23:11:07.798289+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"HTFL DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1464521/000119312526189307/d54880ddef14a.htm","published_at":"2026-04-29T00:00:00+00:00","last_checked_at":"2026-05-04T23:11:07.653444+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"Chief Medical Officer","claim_text":"Carl Dambkowski, M.D. is listed as Chief Medical Officer at Apogee Therapeutics.","claim_state":"verified","valid_from":"2026-04-24","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-14T23:32:07.599947+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"APGE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526177342/apge-20260424.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-14T23:32:07.478893+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"President and Chief Executive Officer","claim_text":"Carole S. Ben-Maimon, M.D. is listed as President and Chief Executive Officer at Larimar Therapeutics, Inc..","claim_state":"verified","valid_from":"2026-04-20","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-04T23:43:38.184993+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"LRMR DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1374690/000119312526163942/lrmr-20260416.htm","published_at":"2026-04-20T00:00:00+00:00","last_checked_at":"2026-05-04T23:43:38.00844+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"Chief Medical Officer","claim_text":"Christopher D. Turner, M.D. is listed as Chief Medical Officer at Nuvalent Inc.","claim_state":"verified","valid_from":"2026-02-26","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T19:40:56.757842+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NUVL 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1861560/000119312526073317/nuvl-20251231.htm","published_at":"2026-02-26T00:00:00+00:00","last_checked_at":"2026-05-01T19:40:56.595118+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer","claim_text":"Carmen Bozic, M.D. is listed as Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer at Vertex Pharmaceuticals Incorporated.","claim_state":"verified","valid_from":"2026-02-13","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-04-25T00:26:49.682275+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VRTX 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000056/vrtx-20251231.htm","published_at":"2026-02-13T00:00:00+00:00","last_checked_at":"2026-04-25T00:26:49.576305+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":{"title":"Chief Medical Officer","role_type_normalized":"other_executive"},"claim_text":"Christopher D. Turner, M.D. is listed as Chief Medical Officer at Nuvalent Inc.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:36.795186+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NUVL executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:46.329356+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":{"title":"Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer","role_type_normalized":"evp"},"claim_text":"Carmen Bozic, M.D. is listed as Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer at Vertex Pharmaceuticals Incorporated.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:15.433956+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VRTX executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:45.028877+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"independence_status","claim_value":{"is_independent":true},"claim_text":"Board independence status at Regeneron Pharmaceuticals, Inc.: True.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:40.576371+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Regeneron Pharmaceuticals, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:44.446969+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Executive extraction classified technology background for Carl Dambkowski, M.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-14T23:32:07.652711+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"APGE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526177342/apge-20260424.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-14T23:32:07.478893+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Craig B. Thompson, M.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T19:32:09.007309+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"REGN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817925000518/regn013211-def14a.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-15T19:32:08.887014+00:00","relation":"supports","excerpt_locator":null}]}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/craig-b-thompson-m-d#profile","url":"https://registry.alpha.ac/people/craig-b-thompson-m-d","dateModified":"2026-05-15T19:32:08.832+00:00","primaryImageOfPage":{"@type":"ImageObject","@id":"https://registry.alpha.ac/people/craig-b-thompson-m-d#portrait","identifier":"alpha-profile-portrait:craig-b-thompson-m-d:v1","contentUrl":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/ae740981-b7bf-4e7f-92fb-0dc504ef96c4.jpg","url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/ae740981-b7bf-4e7f-92fb-0dc504ef96c4.jpg","caption":"Craig B. Thompson, M.D. profile portrait","creditText":"Alpha governed canonical profile record","datePublished":"2026-09-02T04:20:44.357425+00:00","representativeOfPage":true},"mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/craig-b-thompson-m-d#person","name":"Craig B. Thompson, M.D.","image":{"@type":"ImageObject","@id":"https://registry.alpha.ac/people/craig-b-thompson-m-d#portrait","identifier":"alpha-profile-portrait:craig-b-thompson-m-d:v1","contentUrl":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/ae740981-b7bf-4e7f-92fb-0dc504ef96c4.jpg","url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/ae740981-b7bf-4e7f-92fb-0dc504ef96c4.jpg","caption":"Craig B. Thompson, M.D. profile portrait","creditText":"Alpha governed canonical profile record","datePublished":"2026-09-02T04:20:44.357425+00:00","representativeOfPage":true},"url":"https://registry.alpha.ac/people/craig-b-thompson-m-d"},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817925000518/regn013211-def14a.htm","name":"REGN DEF 14A director slate"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526177342/apge-20260424.htm","name":"APGE DEF 14A executive officers"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","name":"Regeneron Pharmaceuticals, Inc. director board source"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1770069/000119312526191449/d121249ddef14a.htm","name":"MPLT DEF 14A executive officers"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1464521/000119312526189307/d54880ddef14a.htm","name":"HTFL DEF 14A executive officers"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1374690/000119312526163942/lrmr-20260416.htm","name":"LRMR DEF 14A executive officers"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1861560/000119312526073317/nuvl-20251231.htm","name":"NUVL 10-K executive officers"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000056/vrtx-20251231.htm","name":"VRTX 10-K executive officers"}],"mainEntityOfPage":"https://registry.alpha.ac/people/craig-b-thompson-m-d"},"presentation":null,"presentation_authority":"not_published","trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":13,"corroborated":9,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":22,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":10,"distinct_source_count":10,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":13,"corroborated":9,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":22,"corroborated_claims":9,"sources":10,"distinct_sources":10,"role_claims":0,"last_reviewed_at":"2026-05-15T19:32:08.832+00:00","observed_at":"2026-09-13T05:23:05.753257+00:00","freshness_days":120}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"craig-b-thompson-m-d","canonical_url":"https://registry.alpha.ac/people/craig-b-thompson-m-d"},"publication":{"published_at":"2026-09-02T04:20:44.357425+00:00","last_reviewed_at":"2026-05-15T19:32:08.832+00:00","as_of":"2026-09-13T05:23:05.753257+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/craig-b-thompson-m-d","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/craig-b-thompson-m-d","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/craig-b-thompson-m-d.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}